Skip to content
Head to head

Boston Scientific vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: BSX · ABT

Updated 5 minutes ago

1-year performance, rebased to 100

BSX -58.7%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
BSXABT
Snapshot
SectorMedical DevicesMedical Devices
Last price41.98103.00
Change today-2.35%-0.84%
1-year return-56.5%-15.4%
Market cap$60.85B$178.39B
52-week range39.57 – 101.9180.89 – 126.70
Valuation
P/E (TTM)17.7138.29
P/E percentile, own 5-yr range5th99th
P/B2.373.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)1.943.72
Net profit (TTM)$2.81B$6.44B
Revenue (TTM)$21.07B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+1.4%+14.5%
Gross margin69.1%56.9%
Operating margin20.6%13.8%
Net margin16.6%9.7%
Free cash flow (TTM)$1.52B$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership95.6%81.2%
Insider activity (12mo)38 buy / 11 sell36 buy / 12 sell
Short interest (% of float)2.4%1.1%
Analyst consensus64% buy / 36% hold (22)93% buy / 7% hold (15)
Analyst price target$50 (+19%)$122 (+18%)
StockVane view
StockVane Quant RatingE (4)D (22)
Company
Employees59,000115,000
Founded19791900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.